Shaping Microbiota During the First 1000 Days of Life.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
pubmed: 27 1 2019
medline: 8 8 2019
entrez: 26 1 2019
Statut: ppublish

Résumé

The data obtained in prior studies suggest that early microbial exposition begins prior to conception and gestation. Given that the host-microbe interaction is shaped by the immune system response, it is important to understand the key immune system-microbiota relationship during the period from conception to the first years of life. The present work summarizes the available evidence concerning early microbiota exposure within the male and the female reproductive tracts at the point of conception and during gestation, focusing on the potential impact on infant development during the first 1000 days of life. Furthermore, we conclude that some dietary strategies including specific probiotics could become potentially valuable tools to modulate the gut microbiota during this early critical window of opportunity for targeted health outcomes throughout the entire lifespan.

Identifiants

pubmed: 30680645
doi: 10.1007/5584_2018_312
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

3-24

Auteurs

Marta Selma-Royo (M)

Department of Biotechnology, Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain.

Maria Tarrazó (M)

Service of Obstetrics and Gynecology, Hospital Universtario Doctor Peset, Valencia, Spain.

Izaskun García-Mantrana (I)

Department of Biotechnology, Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain.

Carlos Gómez-Gallego (C)

Functional Foods Forum, University of Turku, Turku, Finland.
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Seppo Salminen (S)

Functional Foods Forum, University of Turku, Turku, Finland.

Maria Carmen Collado (MC)

Department of Biotechnology, Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain. mcolam@iata.csic.es.
Functional Foods Forum, University of Turku, Turku, Finland. mcolam@iata.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH